Business Description

Johnson & Johnson
NAICS : 325412
SIC : 2834
Compare
Compare
Traded in other countries / regions
JNJ.ArgentinaJNJ.AustriaJNJB34.BrazilJNJ.ChileJNJ.GermanyJNJ_KZ.KazakhstanJNJ.MexicoJNJ.PeruJNJ.Switzerland0R34.UKJNJ.UkraineJNJ.USA IPO Date
1944-09-25Description
Johnson & Johnson is the world's largest and most diverse healthcare firm. Three divisions make up the firm: pharmaceutical, medical devices and diagnostics, and consumer. The drug and device groups represent close to 80% of sales and drive the majority of cash flows for the firm. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. The device segment focuses on orthopedics, surgery tools, vision care, and a few smaller areas. The last segment of consumer focuses on baby care, beauty, oral care, over-the-counter drugs, and women's health. Geographically, just over half of total revenue is generated in the United States.
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.59 | |||||
Equity-to-Asset | 0.41 | |||||
Debt-to-Equity | 0.52 | |||||
Debt-to-EBITDA | 1.37 | |||||
Interest Coverage | 85.88 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 4.43 | |||||
Beneish M-Score | -2.47 | |||||
WACC vs ROIC |
Growth Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 5.2 | |||||
3-Year EBITDA Growth Rate | 5.8 | |||||
3-Year EPS without NRI Growth Rate | 6.1 | |||||
3-Year FCF Growth Rate | -4.6 | |||||
3-Year Book Growth Rate | 9.2 | |||||
Future 3-5Y EPS without NRI Growth Rate | 3.64 | |||||
Future 3-5Y Total Revenue Growth Rate | 2.61 |
Momentum Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 49.45 | |||||
9-Day RSI | 44.45 | |||||
14-Day RSI | 40.8 | |||||
6-1 Month Momentum % | -6.45 | |||||
12-1 Month Momentum % | -11 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.99 | |||||
Quick Ratio | 0.77 | |||||
Cash Ratio | 0.42 | |||||
Days Inventory | 133.78 | |||||
Days Sales Outstanding | 60.79 | |||||
Days Payable | 122.07 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 2.96 | |||||
Dividend Payout Ratio | 0.66 | |||||
3-Year Dividend Growth Rate | 5.9 | |||||
Forward Dividend Yield % | 2.96 | |||||
5-Year Yield-on-Cost % | 3.96 | |||||
3-Year Average Share Buyback Ratio | 0.2 |
Profitability Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 67.26 | |||||
Operating Margin % | 24.97 | |||||
Net Margin % | 18.9 | |||||
ROE % | 23.83 | |||||
ROA % | 9.96 | |||||
ROIC % | 15.31 | |||||
ROC (Joel Greenblatt) % | 117.06 | |||||
ROCE % | 16.52 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 22.65 | |||||
Forward PE Ratio | 14.51 | |||||
PE Ratio without NRI | 22.65 | |||||
Shiller PE Ratio | 24.32 | |||||
Price-to-Owner-Earnings | 25.35 | |||||
PEG Ratio | 5.03 | |||||
PS Ratio | 4.28 | |||||
PB Ratio | 5.19 | |||||
Price-to-Free-Cash-Flow | 23.65 | |||||
Price-to-Operating-Cash-Flow | 19.17 | |||||
EV-to-EBIT | 22.38 | |||||
EV-to-Forward-EBIT | 15.94 | |||||
EV-to-EBITDA | 17 | |||||
EV-to-Forward-EBITDA | 14.12 | |||||
EV-to-Revenue | 5.19 | |||||
EV-to-Forward-Revenue | 5.04 | |||||
EV-to-FCF | 28.65 | |||||
Price-to-Projected-FCF | 1.59 | |||||
Price-to-DCF (Earnings Based) | 1.81 | |||||
Price-to-DCF (FCF Based) | 1.88 | |||||
Price-to-Median-PS-Value | 0.93 | |||||
Earnings Yield (Greenblatt) % | 4.47 | |||||
Forward Rate of Return (Yacktman) % | 8.65 |
How Johnson & Johnson (JNJ) Makes Its Money
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NYSE:JNJ
Peter Lynch Chart
Performance
Dividend
Log
Annualized Return %
Total Annual Return %
Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 94,943 | ||
EPS (TTM) ($) | 6.74 | ||
Beta | 0.43 | ||
Volatility % | 16.62 | ||
14-Day RSI | 40.8 | ||
14-Day ATR ($) | 2.27975 | ||
20-Day SMA ($) | 153.187 | ||
12-1 Month Momentum % | -11 | ||
52-Week Range ($) | 150.11 - 186.69 | ||
Shares Outstanding (Mil) | 3,119.84 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Johnson & Johnson Filings
Document | Form | Filing Date | ||
---|---|---|---|---|
No Filing Data |
Johnson & Johnson Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Johnson & Johnson Frequently Asked Questions
What is Johnson & Johnson(JNJ)'s stock price today?
The current price of JNJ is $152.65. The 52 week high of JNJ is $186.69 and 52 week low is $150.11.
When is next earnings date of Johnson & Johnson(JNJ)?
The next earnings date of Johnson & Johnson(JNJ) is 2023-04-18.
Does Johnson & Johnson(JNJ) pay dividends? If so, how much?
The Dividend Yield %  of Johnson & Johnson(JNJ) is 2.96% (As of Today), Highest Dividend Payout Ratio of Johnson & Johnson(JNJ) was 7.06. The lowest was 0.48. And the median was 0.58. The  Forward Dividend Yield % of Johnson & Johnson(JNJ) is 2.96%. For more information regarding to dividend, please check our Dividend Page.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |